Bryan Yeo
Group chief investment officer and director of the Integrated Strategies Group at GIC
GIC, with an estimated $800 billion in assets under management per PitchBook, is one of three investment entities in Singapore that manages the country’s reserves. According to the company’s website, in fact, GIC handles the majority of the government’s financial assets. It is currently the world’s eighth-
largest sovereign wealth fund, according to the Sovereign Wealth Fund Institute.
Along with the two other firms, Temasek and the Monetary Authority of Singapore, GIC notched net investment returns in 2024 equivalent to $18.23 billion. This fund assists the country’s government in making investments in education, health care, research and development, and Singapore’s “physical environment,” according to the company’s website.
Yeo joined GIC’s fixed-income department as a portfolio manager in 2003 and steadily rose through the ranks, eventually becoming chief investment officer for public equities in 2016, director of the Integrated Strategies Group in 2024, and group chief investment officer in April 2025. He replaced Jeffrey Jaensubhakij, who spent almost 30 years in the role.
Yeo — who earned an engineering degree from the University of Cambridge and a master’s in financial math from the University of Chicago — now manages GIC’s complete investment portfolio, and the development of the company’s investment strategies.
GIC’s assets under management have grown exponentially over the past 15 years, evolving from $247.5 billion in AUM in 2011. The company has grown in size, too, from roughly 1,400 employees in 2017 to more than 2,300 in 2024.
Bloomberg noted that in an August 2024 speech, Yeo cited “artificial intelligence, energy transition, health care and digitalization” as the “biggest investment trends to watch.”
This month, in its most recently announced transaction, GIC was part of a consortium led by Partners Group that purchased Techem, an “international provider of digitally enabled solutions for the real estate sector” for $7.3 billion.
And, in March 2025, the company paired with Temasek and TPG to acquire a “significant stake” in biotech research organization Novotech.
